Key Takeaways
- • Blackstone reported Q1 2026 earnings of $1.36 EPS, beating consensus estimates of $1.34 EPS, with revenue up 10% year-over-year and distributable earnings rising 19% in the same period.
- • The firm is positioned at the center of AI infrastructure financing, with reported discussions on a landmark $35 billion private-credit facility for Broadcom's AI chip development, alongside a $1.5 billion Anthropic venture with Goldman Sachs and a planned $1.7+ billion data center REIT IPO (BXDC).
- • Blackstone's stock closed modestly higher on earnings (up 0.61%) but remains 44–45% below its 52-week high despite record assets under management and fee-related earnings growth of 9%, reflecting persistent valuation and private credit sentiment headwinds since January.
- • Recent dealmaking activity includes a $250 million Life Sciences investment in Anagram Therapeutics, reported bidding for a €2.9 billion German media acquisition (Stroeer), and a $100 million capital injection into Medallia as part of debt restructuring.
- • Free cash flow is estimated to nearly double in 2026, and the firm's 1-month performance stands at +8.5% to +11%, with analyst sentiment remaining constructive despite near-term macro uncertainties.
Summary
Blackstone reported stronger-than-expected Q1 2026 results, delivering earnings per share of $1.36 against consensus expectations of $1.34, alongside 10% year-over-year revenue growth and distributable earnings expansion of 19%. The earnings beat reflects robust underlying operating performance, with fee-related earnings growing 9% and net income totaling $649.7 million (83 cents per share), up from $614.9 million (80 cents) in the prior-year quarter. Despite the positive earnings surprise, equity market sentiment remained cautious, with Blackstone's stock closing modestly higher at up 0.61% as investors contended with a significant gap between operational performance and stock valuation—the shares remain approximately 44–45% below their 52-week highs.
The earnings beat occurred against a backdrop of substantial strategic momentum in private credit and AI infrastructure finance. Bloomberg reported that Blackstone and Apollo are in advanced discussions to arrange a $35 billion private-credit facility for Broadcom to fund AI chip development, representing one of the largest private credit commitments on record and demonstrating institutional capital's accelerating pivot toward AI infrastructure. This facility underscores Blackstone's competitive positioning in AI-adjacent dealmaking, complemented by its announced $1.5 billion joint venture with Goldman Sachs in Anthropic and its upcoming data center REIT IPO (BXDC), valued at approximately $1.74 billion, which further embeds the firm within the AI buildout narrative.
Beyond headline-grabbing AI deals, Blackstone has maintained operational momentum across diversified asset classes. The Life Sciences unit committed $250 million to Anagram Therapeutics, the firm was reported as a co-bidder on a potential €2.9 billion acquisition of German media group Stroeer alongside I Squared Capital, and Blackstone is leading a $100 million capital injection into software platform Medallia as part of a comprehensive debt restructuring. These transactions reflect active deployment of capital and fee-earning activity across private equity, credit, and growth equity verticals.
The disconnect between Blackstone's operational strength and stock performance reflects broader market concerns about private credit valuations and elevated interest rate expectations following a robust April jobs report. Peer Brookfield Asset Management reported Q1 results with 11% fee-related earnings growth, signaling healthy fundraising momentum across alternative asset managers, yet Blackstone's premium historical valuation multiples appear to be compressing under macro uncertainty. Management guidance and analyst commentary suggest buying opportunities remain despite sentiment headwinds, with free cash flow estimated to nearly double in 2026 and record assets under management providing a substantial earnings tailwind if sentiment stabilizes.
The earnings beat occurred against a backdrop of substantial strategic momentum in private credit and AI infrastructure finance. Bloomberg reported that Blackstone and Apollo are in advanced discussions to arrange a $35 billion private-credit facility for Broadcom to fund AI chip development, representing one of the largest private credit commitments on record and demonstrating institutional capital's accelerating pivot toward AI infrastructure. This facility underscores Blackstone's competitive positioning in AI-adjacent dealmaking, complemented by its announced $1.5 billion joint venture with Goldman Sachs in Anthropic and its upcoming data center REIT IPO (BXDC), valued at approximately $1.74 billion, which further embeds the firm within the AI buildout narrative.
Beyond headline-grabbing AI deals, Blackstone has maintained operational momentum across diversified asset classes. The Life Sciences unit committed $250 million to Anagram Therapeutics, the firm was reported as a co-bidder on a potential €2.9 billion acquisition of German media group Stroeer alongside I Squared Capital, and Blackstone is leading a $100 million capital injection into software platform Medallia as part of a comprehensive debt restructuring. These transactions reflect active deployment of capital and fee-earning activity across private equity, credit, and growth equity verticals.
The disconnect between Blackstone's operational strength and stock performance reflects broader market concerns about private credit valuations and elevated interest rate expectations following a robust April jobs report. Peer Brookfield Asset Management reported Q1 results with 11% fee-related earnings growth, signaling healthy fundraising momentum across alternative asset managers, yet Blackstone's premium historical valuation multiples appear to be compressing under macro uncertainty. Management guidance and analyst commentary suggest buying opportunities remain despite sentiment headwinds, with free cash flow estimated to nearly double in 2026 and record assets under management providing a substantial earnings tailwind if sentiment stabilizes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.